rs4135012

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001254.4(CDC6):​c.883G>A​(p.Asp295Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0198 in 1,613,948 control chromosomes in the GnomAD database, including 364 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.015 ( 30 hom., cov: 32)
Exomes 𝑓: 0.020 ( 334 hom. )

Consequence

CDC6
NM_001254.4 missense

Scores

4
5
9

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 8.43

Publications

21 publications found
Variant links:
Genes affected
CDC6 (HGNC:1744): (cell division cycle 6) The protein encoded by this gene is highly similar to Saccharomyces cerevisiae Cdc6, a protein essential for the initiation of DNA replication. This protein functions as a regulator at the early steps of DNA replication. It localizes in cell nucleus during cell cyle G1, but translocates to the cytoplasm at the start of S phase. The subcellular translocation of this protein during cell cyle is regulated through its phosphorylation by Cdks. Transcription of this protein was reported to be regulated in response to mitogenic signals through transcriptional control mechanism involving E2F proteins. [provided by RefSeq, Jul 2008]
CDC6 Gene-Disease associations (from GenCC):
  • Meier-Gorlin syndrome 5
    Inheritance: Unknown, AR Classification: DEFINITIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • Meier-Gorlin syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011202812).
BP6
Variant 17-40293996-G-A is Benign according to our data. Variant chr17-40293996-G-A is described in ClinVar as Benign. ClinVar VariationId is 128638.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0152 (2310/152318) while in subpopulation NFE AF = 0.023 (1565/68030). AF 95% confidence interval is 0.0221. There are 30 homozygotes in GnomAd4. There are 1150 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 30 AD,Unknown,AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
CDC6NM_001254.4 linkc.883G>A p.Asp295Asn missense_variant Exon 6 of 12 ENST00000209728.9 NP_001245.1 Q99741A0A024R1S2
CDC6XM_011525541.3 linkc.883G>A p.Asp295Asn missense_variant Exon 6 of 13 XP_011523843.1
CDC6XM_011525542.2 linkc.883G>A p.Asp295Asn missense_variant Exon 6 of 13 XP_011523844.1
CDC6XM_047437207.1 linkc.883G>A p.Asp295Asn missense_variant Exon 6 of 12 XP_047293163.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
CDC6ENST00000209728.9 linkc.883G>A p.Asp295Asn missense_variant Exon 6 of 12 1 NM_001254.4 ENSP00000209728.4 Q99741
CDC6ENST00000649662.1 linkc.883G>A p.Asp295Asn missense_variant Exon 6 of 12 ENSP00000497345.1 Q99741
CDC6ENST00000582402.1 linkn.203-1360G>A intron_variant Intron 1 of 1 3

Frequencies

GnomAD3 genomes
AF:
0.0152
AC:
2311
AN:
152200
Hom.:
30
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00369
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0179
Gnomad ASJ
AF:
0.00490
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00477
Gnomad FIN
AF:
0.0230
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.0230
Gnomad OTH
AF:
0.0148
GnomAD2 exomes
AF:
0.0138
AC:
3471
AN:
251476
AF XY:
0.0138
show subpopulations
Gnomad AFR exome
AF:
0.00320
Gnomad AMR exome
AF:
0.00711
Gnomad ASJ exome
AF:
0.00585
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0236
Gnomad NFE exome
AF:
0.0207
Gnomad OTH exome
AF:
0.0168
GnomAD4 exome
AF:
0.0203
AC:
29654
AN:
1461630
Hom.:
334
Cov.:
32
AF XY:
0.0199
AC XY:
14476
AN XY:
727128
show subpopulations
African (AFR)
AF:
0.00311
AC:
104
AN:
33480
American (AMR)
AF:
0.00798
AC:
357
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00597
AC:
156
AN:
26132
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39688
South Asian (SAS)
AF:
0.00530
AC:
457
AN:
86256
European-Finnish (FIN)
AF:
0.0216
AC:
1155
AN:
53416
Middle Eastern (MID)
AF:
0.0130
AC:
75
AN:
5768
European-Non Finnish (NFE)
AF:
0.0236
AC:
26254
AN:
1111780
Other (OTH)
AF:
0.0181
AC:
1096
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
1378
2756
4134
5512
6890
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1002
2004
3006
4008
5010
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0152
AC:
2310
AN:
152318
Hom.:
30
Cov.:
32
AF XY:
0.0154
AC XY:
1150
AN XY:
74494
show subpopulations
African (AFR)
AF:
0.00368
AC:
153
AN:
41568
American (AMR)
AF:
0.0178
AC:
273
AN:
15298
Ashkenazi Jewish (ASJ)
AF:
0.00490
AC:
17
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5194
South Asian (SAS)
AF:
0.00477
AC:
23
AN:
4822
European-Finnish (FIN)
AF:
0.0230
AC:
244
AN:
10614
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.0230
AC:
1565
AN:
68030
Other (OTH)
AF:
0.0147
AC:
31
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
114
227
341
454
568
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
26
52
78
104
130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0185
Hom.:
117
Bravo
AF:
0.0139
TwinsUK
AF:
0.0245
AC:
91
ALSPAC
AF:
0.0249
AC:
96
ESP6500AA
AF:
0.00477
AC:
21
ESP6500EA
AF:
0.0212
AC:
182
ExAC
AF:
0.0131
AC:
1586
Asia WGS
AF:
0.00231
AC:
8
AN:
3478
EpiCase
AF:
0.0204
EpiControl
AF:
0.0205

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Jun 21, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Genome Diagnostics Laboratory, University Medical Center Utrecht
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

CDC6: BS1, BS2 -

Meier-Gorlin syndrome 5 Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.29
BayesDel_addAF
Benign
-0.50
T
BayesDel_noAF
Benign
-0.47
CADD
Pathogenic
28
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.050
T;T;T
Eigen
Pathogenic
0.75
Eigen_PC
Pathogenic
0.79
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.94
.;.;D
MetaRNN
Benign
0.011
T;T;T
MetaSVM
Benign
-0.69
T
MutationAssessor
Benign
1.8
L;L;L
PhyloP100
8.4
PrimateAI
Uncertain
0.67
T
PROVEAN
Uncertain
-2.6
D;.;.
REVEL
Benign
0.22
Sift
Uncertain
0.0090
D;.;.
Sift4G
Uncertain
0.059
T;.;.
Polyphen
0.89
P;P;P
Vest4
0.26
MPC
0.69
ClinPred
0.028
T
GERP RS
6.0
Varity_R
0.61
gMVP
0.65
Mutation Taster
=78/22
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs4135012; hg19: chr17-38450248; COSMIC: COSV99079657; COSMIC: COSV99079657; API